Structure

Physi-Chem Properties

Molecular Weight:  812.36
Volume:  853.907
LogP:  11.323
LogD:  5.289
LogS:  -1.844
# Rotatable Bonds:  11
TPSA:  170.05
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  7
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.043
Synthetic Accessibility Score:  5.031
Fsp3:  0.3
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.965
MDCK Permeability:  1.1173007806064561e-05
Pgp-inhibitor:  0.888
Pgp-substrate:  0.939
Human Intestinal Absorption (HIA):  0.631
20% Bioavailability (F20%):  0.989
30% Bioavailability (F30%):  0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  106.2026138305664%
Volume Distribution (VD):  0.772
Pgp-substrate:  12.636406898498535%

ADMET: Metabolism

CYP1A2-inhibitor:  0.074
CYP1A2-substrate:  0.196
CYP2C19-inhibitor:  0.818
CYP2C19-substrate:  0.048
CYP2C9-inhibitor:  0.609
CYP2C9-substrate:  0.627
CYP2D6-inhibitor:  0.038
CYP2D6-substrate:  0.168
CYP3A4-inhibitor:  0.076
CYP3A4-substrate:  0.122

ADMET: Excretion

Clearance (CL):  12.615
Half-life (T1/2):  0.014

ADMET: Toxicity

hERG Blockers:  0.036
Human Hepatotoxicity (H-HT):  0.995
Drug-inuced Liver Injury (DILI):  0.988
AMES Toxicity:  0.258
Rat Oral Acute Toxicity:  0.909
Maximum Recommended Daily Dose:  0.978
Skin Sensitization:  0.932
Carcinogencity:  0.044
Eye Corrosion:  0.003
Eye Irritation:  0.877
Respiratory Toxicity:  0.04

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC304322

Natural Product ID:  NPC304322
Common Name*:   Lespeflorin J3
IUPAC Name:   [(6aR,11aR)-3,9-dihydroxy-2,10-bis(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-8-yl]-[2-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-7-(3-methylbut-2-enyl)-1-benzofuran-3-yl]methanone
Synonyms:   Lespeflorin J3
Standard InCHIKey:  BEZJLLIBPJHWLI-HNKXTRRSSA-N
Standard InCHI:  InChI=1S/C50H52O10/c1-24(2)9-13-28-17-33(40(53)21-38(28)51)50-43(35-20-41(54)45(56)31(48(35)60-50)16-12-27(7)8)46(57)36-19-32-37-23-58-42-22-39(52)29(14-10-25(3)4)18-34(42)49(37)59-47(32)30(44(36)55)15-11-26(5)6/h9-12,17-22,37,49,51-56H,13-16,23H2,1-8H3/t37-,49-/m0/s1
SMILES:  CC(=CCc1c2O[C@@H]3[C@H](c2cc(c1O)C(=O)c1c(oc2c1cc(O)c(c2CC=C(C)C)O)c1cc(CC=C(C)C)c(cc1O)O)COc1c3cc(CC=C(C)C)c(c1)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL557191
PubChem CID:   25243394
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19102656]
NPO13293 Lespedeza floribunda Species Fabaceae Eukaryota roots n.a. n.a. PMID[19132934]
NPO13293 Lespedeza floribunda Species Fabaceae Eukaryota n.a. root n.a. PMID[19132934]
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10080 Teucrium betonicum Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13293 Lespedeza floribunda Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 37700.0 nM PMID[470837]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC304322 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9941 High Similarity NPC139683
0.9941 High Similarity NPC73929
0.9941 High Similarity NPC47905
0.92 High Similarity NPC150977
0.9176 High Similarity NPC50394
0.9172 High Similarity NPC37183
0.9128 High Similarity NPC248593
0.9128 High Similarity NPC174700
0.9128 High Similarity NPC28589
0.9118 High Similarity NPC277480
0.9086 High Similarity NPC185275
0.9029 High Similarity NPC475783
0.9029 High Similarity NPC471789
0.9029 High Similarity NPC265380
0.9012 High Similarity NPC53252
0.9006 High Similarity NPC320741
0.9006 High Similarity NPC171985
0.9006 High Similarity NPC224851
0.9 High Similarity NPC38591
0.8977 High Similarity NPC324742
0.8966 High Similarity NPC473834
0.8966 High Similarity NPC261471
0.8966 High Similarity NPC310794
0.8966 High Similarity NPC37606
0.896 High Similarity NPC218533
0.896 High Similarity NPC78830
0.8947 High Similarity NPC291110
0.8941 High Similarity NPC473012
0.8914 High Similarity NPC300657
0.8902 High Similarity NPC107627
0.8895 High Similarity NPC251336
0.8889 High Similarity NPC472278
0.8889 High Similarity NPC473313
0.8889 High Similarity NPC473009
0.8889 High Similarity NPC329669
0.8882 High Similarity NPC301256
0.8882 High Similarity NPC312273
0.8864 High Similarity NPC156955
0.8864 High Similarity NPC164384
0.8857 High Similarity NPC149846
0.8851 High Similarity NPC131866
0.8844 High Similarity NPC253730
0.8844 High Similarity NPC86477
0.8844 High Similarity NPC286230
0.8844 High Similarity NPC247973
0.8837 High Similarity NPC259757
0.8837 High Similarity NPC473010
0.88 High Similarity NPC472454
0.88 High Similarity NPC186847
0.88 High Similarity NPC257667
0.8793 High Similarity NPC300307
0.8793 High Similarity NPC475212
0.8786 High Similarity NPC272560
0.8779 High Similarity NPC273959
0.8765 High Similarity NPC40583
0.8757 High Similarity NPC216307
0.8757 High Similarity NPC8127
0.8757 High Similarity NPC49667
0.875 High Similarity NPC117450
0.8743 High Similarity NPC279209
0.8743 High Similarity NPC476365
0.8743 High Similarity NPC180768
0.8743 High Similarity NPC102277
0.8736 High Similarity NPC14662
0.8736 High Similarity NPC243877
0.8728 High Similarity NPC169471
0.8728 High Similarity NPC300053
0.8728 High Similarity NPC473286
0.8728 High Similarity NPC39306
0.8728 High Similarity NPC326520
0.8728 High Similarity NPC477840
0.8721 High Similarity NPC312056
0.8721 High Similarity NPC81679
0.8721 High Similarity NPC220912
0.8721 High Similarity NPC84515
0.8715 High Similarity NPC97523
0.8713 High Similarity NPC304839
0.8713 High Similarity NPC220582
0.8701 High Similarity NPC99591
0.8701 High Similarity NPC287243
0.8698 High Similarity NPC113906
0.8693 High Similarity NPC212038
0.8693 High Similarity NPC271848
0.8693 High Similarity NPC81332
0.8693 High Similarity NPC262580
0.8693 High Similarity NPC4200
0.8693 High Similarity NPC289396
0.8693 High Similarity NPC307286
0.8693 High Similarity NPC100251
0.8681 High Similarity NPC473618
0.8678 High Similarity NPC119589
0.8678 High Similarity NPC170245
0.8678 High Similarity NPC173292
0.8678 High Similarity NPC53640
0.8678 High Similarity NPC128293
0.8671 High Similarity NPC18100
0.8671 High Similarity NPC133065
0.8667 High Similarity NPC471842
0.8663 High Similarity NPC45124
0.8663 High Similarity NPC228383
0.8663 High Similarity NPC472275
0.8663 High Similarity NPC142252
0.8663 High Similarity NPC266314
0.8663 High Similarity NPC188486
0.8663 High Similarity NPC30655
0.8663 High Similarity NPC74854
0.8659 High Similarity NPC473785
0.8655 High Similarity NPC469658
0.8655 High Similarity NPC15815
0.8655 High Similarity NPC196879
0.8652 High Similarity NPC478050
0.8652 High Similarity NPC471841
0.8652 High Similarity NPC101991
0.8644 High Similarity NPC82217
0.8644 High Similarity NPC216842
0.8644 High Similarity NPC476640
0.8644 High Similarity NPC98583
0.8644 High Similarity NPC65885
0.8639 High Similarity NPC298692
0.8636 High Similarity NPC472276
0.8636 High Similarity NPC103307
0.8636 High Similarity NPC120220
0.8629 High Similarity NPC476459
0.8629 High Similarity NPC260266
0.8626 High Similarity NPC179947
0.8621 High Similarity NPC472277
0.8621 High Similarity NPC29411
0.8619 High Similarity NPC154527
0.8613 High Similarity NPC476247
0.8613 High Similarity NPC219927
0.8613 High Similarity NPC473011
0.8613 High Similarity NPC477841
0.8611 High Similarity NPC47883
0.8611 High Similarity NPC117668
0.8605 High Similarity NPC98023
0.8605 High Similarity NPC195136
0.8605 High Similarity NPC188967
0.8605 High Similarity NPC226462
0.8603 High Similarity NPC207467
0.8603 High Similarity NPC246877
0.8596 High Similarity NPC236796
0.8596 High Similarity NPC289244
0.8596 High Similarity NPC271741
0.8596 High Similarity NPC262286
0.8596 High Similarity NPC227906
0.8596 High Similarity NPC36852
0.8596 High Similarity NPC469584
0.8596 High Similarity NPC287789
0.8596 High Similarity NPC223787
0.8596 High Similarity NPC1796
0.8596 High Similarity NPC257166
0.8588 High Similarity NPC230619
0.8588 High Similarity NPC477836
0.8588 High Similarity NPC79375
0.8588 High Similarity NPC65333
0.8588 High Similarity NPC54098
0.8588 High Similarity NPC121333
0.8588 High Similarity NPC37253
0.8588 High Similarity NPC472584
0.8588 High Similarity NPC477529
0.8587 High Similarity NPC264302
0.858 High Similarity NPC125300
0.858 High Similarity NPC152477
0.858 High Similarity NPC242395
0.858 High Similarity NPC211309
0.858 High Similarity NPC106976
0.858 High Similarity NPC5871
0.858 High Similarity NPC288813
0.8571 High Similarity NPC207575
0.8571 High Similarity NPC43065
0.8571 High Similarity NPC112380
0.8571 High Similarity NPC120593
0.8571 High Similarity NPC226725
0.8571 High Similarity NPC235610
0.8571 High Similarity NPC13481
0.8571 High Similarity NPC82330
0.8564 High Similarity NPC321916
0.8564 High Similarity NPC132111
0.8563 High Similarity NPC7483
0.8563 High Similarity NPC472281
0.8563 High Similarity NPC272064
0.8563 High Similarity NPC205265
0.8563 High Similarity NPC159508
0.8563 High Similarity NPC475985
0.8563 High Similarity NPC41301
0.8563 High Similarity NPC124038
0.8556 High Similarity NPC121888
0.8556 High Similarity NPC183843
0.8555 High Similarity NPC471211
0.8555 High Similarity NPC475883
0.8555 High Similarity NPC231758
0.8555 High Similarity NPC158188
0.8555 High Similarity NPC40491
0.8555 High Similarity NPC474351
0.8555 High Similarity NPC474186
0.8555 High Similarity NPC471212
0.8555 High Similarity NPC134783
0.8555 High Similarity NPC278052
0.8547 High Similarity NPC95936
0.8547 High Similarity NPC329091

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC304322 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8529 High Similarity NPD2393 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD5494 Approved
0.8448 Intermediate Similarity NPD6959 Discontinued
0.8409 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8409 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8409 Intermediate Similarity NPD6166 Phase 2
0.8372 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8324 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8256 Intermediate Similarity NPD1934 Approved
0.8208 Intermediate Similarity NPD2801 Approved
0.8202 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8156 Intermediate Similarity NPD7473 Discontinued
0.8122 Intermediate Similarity NPD7074 Phase 3
0.8118 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8114 Intermediate Similarity NPD3882 Suspended
0.8111 Intermediate Similarity NPD3818 Discontinued
0.8066 Intermediate Similarity NPD5844 Phase 1
0.8066 Intermediate Similarity NPD7054 Approved
0.8035 Intermediate Similarity NPD4380 Phase 2
0.8033 Intermediate Similarity NPD6559 Discontinued
0.8022 Intermediate Similarity NPD7472 Approved
0.8011 Intermediate Similarity NPD7768 Phase 2
0.8 Intermediate Similarity NPD7819 Suspended
0.7989 Intermediate Similarity NPD6232 Discontinued
0.7966 Intermediate Similarity NPD7075 Discontinued
0.7966 Intermediate Similarity NPD3749 Approved
0.7944 Intermediate Similarity NPD3926 Phase 2
0.7935 Intermediate Similarity NPD7251 Discontinued
0.7895 Intermediate Similarity NPD1511 Approved
0.7892 Intermediate Similarity NPD7808 Phase 3
0.7892 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD7411 Suspended
0.788 Intermediate Similarity NPD6797 Phase 2
0.7869 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7842 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD1247 Approved
0.7803 Intermediate Similarity NPD1512 Approved
0.7797 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7766 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD8312 Approved
0.7754 Intermediate Similarity NPD8313 Approved
0.7746 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7717 Intermediate Similarity NPD7228 Approved
0.7706 Intermediate Similarity NPD1549 Phase 2
0.7697 Intermediate Similarity NPD1465 Phase 2
0.7654 Intermediate Similarity NPD3817 Phase 2
0.7647 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD2344 Approved
0.7624 Intermediate Similarity NPD6234 Discontinued
0.7612 Intermediate Similarity NPD8151 Discontinued
0.7586 Intermediate Similarity NPD7390 Discontinued
0.7558 Intermediate Similarity NPD2800 Approved
0.7556 Intermediate Similarity NPD5402 Approved
0.7543 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD6801 Discontinued
0.7539 Intermediate Similarity NPD8434 Phase 2
0.7527 Intermediate Similarity NPD919 Approved
0.7485 Intermediate Similarity NPD2796 Approved
0.7471 Intermediate Similarity NPD2309 Approved
0.7458 Intermediate Similarity NPD920 Approved
0.7443 Intermediate Similarity NPD2534 Approved
0.7443 Intermediate Similarity NPD2533 Approved
0.7443 Intermediate Similarity NPD2532 Approved
0.7433 Intermediate Similarity NPD3751 Discontinued
0.7427 Intermediate Similarity NPD1510 Phase 2
0.7418 Intermediate Similarity NPD4967 Phase 2
0.7418 Intermediate Similarity NPD4966 Approved
0.7418 Intermediate Similarity NPD4965 Approved
0.7413 Intermediate Similarity NPD7871 Phase 2
0.7413 Intermediate Similarity NPD7870 Phase 2
0.7387 Intermediate Similarity NPD6778 Approved
0.7387 Intermediate Similarity NPD6781 Approved
0.7387 Intermediate Similarity NPD6779 Approved
0.7387 Intermediate Similarity NPD6776 Approved
0.7387 Intermediate Similarity NPD6780 Approved
0.7387 Intermediate Similarity NPD6777 Approved
0.7387 Intermediate Similarity NPD6782 Approved
0.7363 Intermediate Similarity NPD7698 Approved
0.7363 Intermediate Similarity NPD7435 Discontinued
0.7363 Intermediate Similarity NPD7696 Phase 3
0.7363 Intermediate Similarity NPD7697 Approved
0.7358 Intermediate Similarity NPD8150 Discontinued
0.7356 Intermediate Similarity NPD1243 Approved
0.7351 Intermediate Similarity NPD7199 Phase 2
0.7345 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD3787 Discontinued
0.7308 Intermediate Similarity NPD8455 Phase 2
0.7304 Intermediate Similarity NPD7701 Phase 2
0.7294 Intermediate Similarity NPD1240 Approved
0.7294 Intermediate Similarity NPD943 Approved
0.7288 Intermediate Similarity NPD6799 Approved
0.7283 Intermediate Similarity NPD2935 Discontinued
0.7282 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD7783 Phase 2
0.7282 Intermediate Similarity NPD7801 Approved
0.7278 Intermediate Similarity NPD3226 Approved
0.7277 Intermediate Similarity NPD7240 Approved
0.7273 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD37 Approved
0.7249 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD6599 Discontinued
0.7233 Intermediate Similarity NPD7874 Approved
0.7233 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7229 Phase 3
0.7214 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD6651 Approved
0.7209 Intermediate Similarity NPD1607 Approved
0.72 Intermediate Similarity NPD7699 Phase 2
0.72 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7700 Phase 2
0.7188 Intermediate Similarity NPD7685 Pre-registration
0.7176 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD5403 Approved
0.7151 Intermediate Similarity NPD230 Phase 1
0.7151 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6823 Phase 2
0.7136 Intermediate Similarity NPD6535 Approved
0.7136 Intermediate Similarity NPD6534 Approved
0.7135 Intermediate Similarity NPD5953 Discontinued
0.712 Intermediate Similarity NPD5760 Phase 2
0.712 Intermediate Similarity NPD5761 Phase 2
0.7119 Intermediate Similarity NPD3750 Approved
0.7108 Intermediate Similarity NPD7680 Approved
0.7107 Intermediate Similarity NPD4287 Approved
0.7093 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD1613 Approved
0.7088 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6100 Approved
0.7086 Intermediate Similarity NPD6099 Approved
0.7059 Intermediate Similarity NPD4908 Phase 1
0.7056 Intermediate Similarity NPD5401 Approved
0.7037 Intermediate Similarity NPD5711 Approved
0.7037 Intermediate Similarity NPD5710 Approved
0.7031 Intermediate Similarity NPD7286 Phase 2
0.7029 Intermediate Similarity NPD2799 Discontinued
0.7022 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.6995 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6995 Remote Similarity NPD7458 Discontinued
0.699 Remote Similarity NPD8320 Phase 1
0.699 Remote Similarity NPD8319 Approved
0.6989 Remote Similarity NPD2296 Approved
0.6984 Remote Similarity NPD8127 Discontinued
0.6983 Remote Similarity NPD6190 Approved
0.6977 Remote Similarity NPD7907 Approved
0.6977 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6968 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6965 Remote Similarity NPD4363 Phase 3
0.6965 Remote Similarity NPD4360 Phase 2
0.6959 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6949 Remote Similarity NPD2346 Discontinued
0.694 Remote Similarity NPD1653 Approved
0.6932 Remote Similarity NPD651 Clinical (unspecified phase)
0.6927 Remote Similarity NPD4628 Phase 3
0.6927 Remote Similarity NPD8166 Discontinued
0.6915 Remote Similarity NPD6212 Phase 3
0.6915 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6915 Remote Similarity NPD6213 Phase 3
0.6893 Remote Similarity NPD5404 Approved
0.6893 Remote Similarity NPD5405 Approved
0.6893 Remote Similarity NPD5406 Approved
0.6893 Remote Similarity NPD5408 Approved
0.6893 Remote Similarity NPD1551 Phase 2
0.6882 Remote Similarity NPD6280 Approved
0.6882 Remote Similarity NPD6844 Discontinued
0.6882 Remote Similarity NPD6279 Approved
0.6879 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6859 Remote Similarity NPD6808 Phase 2
0.6854 Remote Similarity NPD1471 Phase 3
0.6842 Remote Similarity NPD7584 Approved
0.6836 Remote Similarity NPD3748 Approved
0.6833 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6833 Remote Similarity NPD7003 Approved
0.6828 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6821 Remote Similarity NPD3027 Phase 3
0.6818 Remote Similarity NPD8059 Phase 3
0.6818 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6806 Remote Similarity NPD4665 Approved
0.6806 Remote Similarity NPD4111 Phase 1
0.6804 Remote Similarity NPD7177 Discontinued
0.6802 Remote Similarity NPD2861 Phase 2
0.6802 Remote Similarity NPD7549 Discontinued
0.6782 Remote Similarity NPD2313 Discontinued
0.6765 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6765 Remote Similarity NPD4361 Phase 2
0.6761 Remote Similarity NPD447 Suspended
0.6748 Remote Similarity NPD8285 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data